UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C902. A total of 4 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,275,115 | +261.9% | 14,500 | +253.7% | 0.00% | – |
| Q2 2023 | $905,075 | -92.9% | 4,100 | -92.8% | 0.00% | -100.0% |
| Q1 2023 | $12,810,512 | -21.7% | 57,200 | -2.7% | 0.01% | -37.5% |
| Q4 2022 | $16,351,692 | +114.6% | 58,800 | +61.5% | 0.01% | +166.7% |
| Q3 2022 | $7,621,000 | -52.8% | 36,400 | -46.9% | 0.00% | -57.1% |
| Q2 2022 | $16,141,000 | – | 68,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 79 | $1,199,000 | 0.04% |
| SIMPLEX TRADING, LLC | 150 | $2,276,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |